Febuxostat placebo

DRUG3 trials

Sponsors

Takeda

Conditions

Coronary Artery DiseaseGoutModerate Renal Impairment

Phase 2

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

CompletedNCT02128490

TakedaGout, Moderate Renal Impairment

Start: 2014-05-31End: 2015-10-31Updated: 2016-11-03

Phase 3

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout

CompletedNCT02139046

Start: 2014-04-30End: 2015-11-30Updated: 2016-11-03

Phase 4

The Influence of Febuxostat on Coronary Artery Endothelial Dysfunction in Participants With Chronic Stable Angina

CompletedNCT01763996

TakedaCoronary Artery Disease

Start: 2013-05-31End: 2015-04-30Updated: 2016-04-13

Related Papers

Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study.

2018-05-3016 citations